Green Chemicals Blog
Earnings
VIDEO: Danimer Scientific debuts on NY Stock Exchange
Meredian Holdings Group, Inc., doing business as Danimer Scientific, a next-generation bioplastics company focused on the development and production of biodegradable materials, and Danimer Scientific, Inc., formerly known as Live Oak Acquisition Corp. have completed their previously announced business combination. Live Oak was a special purpose acquisition company (SPAC) with no commercial operations and was … Continue reading
DowDuPont plans to sell its Biomaterials business
When former DuPont CEO Ellen Kullman was at the helm, DuPont had been keen on building its industrial biosciences business unit as a global powerhouse as it shifted its strategy in expanding this business with the acquisition of Danisco for $7 billion back in 2011. Enzymes, bioactive solutions, biomaterials, and biorefining products were the key … Continue reading
BioAmber files for Bankruptcy
Unfortunately, the force is not that strong for BioAmber today as the company announced its filing for Chapter 11 Bankruptcy in the US, while its two Canadian subsidiaries – BioAmber Sarnia Inc. and BioAmber Canada Inc. also filed a notice of bankruptcy intention as well in Canada. The company said these procedures are the best … Continue reading
Hard times for public renewable chemical companies
The past year and a half (or almost two years) has been very hard for public chemical companies as Codexis and Solazyme (now Terravia) reinvented themselves, while Gevo and Metabolix shareholders seem to be now looking into selling the companies as options due to financial difficulties. Gevo just announced that it hired Cowen & Company to explore … Continue reading
BioAmber Reports Earnings Results
It is 2am in the morning and when I can’t sleep, that means it is time to blog. BioAmber released its 4Q and Full Year 2014 financial results yesterday reporting construction progress and on budget for its 30 ktpa bio-succinic acid plant in Sarnia, Ontario, Canada, with a goal to be in commercial operation by … Continue reading
Solazyme still faces production challenges at Moema
I wonder how long the petrochemical industry had perfected its processing technologies before it was able to reach an economical, efficient level? Unfortunately, investors today are not too forgiving when new, untested technologies from public companies are facing commercialization challenges. Solazyme is now going through this stage and their stocks had plunged from $11.79 a … Continue reading
Turnaround for Amyris
Despite the current water shortage (due to drought) and electricity problems in Brazil, Amyris seems to be doing well according to the company’s third quarter earnings report. Amyris said its Brotas biorefinery plant in Brazil has been running for 3 months without any unscheduled interruptions. The company expects to continue operations until the sugarcane season … Continue reading
BioAmber’s Sarnia bio-succinic acid project on track
BioAmber Inc., an industrial biotechnology company producing sustainable chemicals, recently announced its financial results for the third quarter ended September 30, 2014. Highlights included: Sarnia project continues to be on budget and scheduled for mechanical completion in early 2015 A 15 year take-or-pay agreement was signed with Vinmar for at least 10,000 tons per year from Sarnia … Continue reading
Solazyme, AkzoNobel expand surfactant partnership
Algal oils producer, Solazyme, has expanded its algal oil supply agreement with specialty chemicals company, AkzoNobel, with a new five-year supply of up to 10,000 tons/year of Solazyme’s Tailored™ algal oil for surfactant production pending successful joint product development. The parties expect that the algal oil under the joint development agreement would be able to … Continue reading
Gevo reports cash concern in 10-K
As the blog reported before, 2014 seems to be the year for industry restructuring with LS9 being acquired by Renewable Energy Group; Cereplast filing for bankruptcy and Codexis changing its business strategy and focus. Bio-isobutanol producer, Gevo, is currently in the cross-hair unless the company comes up with more cash this year. Gevo recently warned on … Continue reading